Earnings calendar/KRYS
Krystal Biotech, Inc. (KRYS)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Nov 2, 2026
Consensus estimate row
EPS target
$1.91
Street estimate
Revenue target
$129.6M
Street estimate
Trailing EPS (avg 4Q)
$2.00
Beat rate last 4: 100%
Latest EPS YoY
+38.8%
vs 2025-08-04
Latest revenue YoY
+24.1%
How results look so far
Trailing revenue (avg 4Q)
$110.1M
Printed quarters
EPS beat rate (4Q)
100%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Aug 3, 2026
EPS beat
EPS actual / est
$1.79 / $1.70
+5.3%
Revenue actual / est
$119.2M / $120.9M
-1.4%
Result
Target reached
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 11/2/2026upcoming | $1.91 | Pending | — | $129.6M | Pending | — |
| 8/3/2026 | $1.70 | $1.79 | +5.3% | $120.9M | $119.2M | -1.4% |
| 5/5/2026upcoming | $1.51 | Pending | — | $112.1M | Pending | — |
| 5/4/2026 | $1.45 | $1.83 | +26.2% | $112.1M | $116.4M | +3.8% |
| 2/18/2026upcoming | $1.62 | Pending | — | — | Pending | — |
| 2/17/2026 | $1.62 | $1.70 | +4.9% | $105.3M | $107.1M | +1.7% |
| 11/3/2025 | $1.12 | $2.66 | +137.5% | $105.3M | $97.8M | -7.1% |
| 8/4/2025 | $1.08 | $1.29 | +19.4% | $95.4M | $96.0M | +0.7% |
| 5/6/2025 | $1.38 | $1.20 | -13.0% | $106.0M | $88.2M | -16.8% |
| 2/19/2025 | $1.29 | $1.52 | +17.8% | $91.4M | $91.1M | -0.2% |
| 11/4/2024 | $0.90 | $0.91 | +1.1% | $91.3M | $83.8M | -8.2% |
| 8/5/2024 | $0.50 | $0.53 | +6.0% | $65.3M | $70.3M | +7.7% |
| 5/6/2024 | $0.15 | $0.03 | -80.0% | $47.4M | $45.3M | -4.6% |
| 2/26/2024 | $-0.38 | $0.30 | +178.9% | $29.2M | $42.1M | +44.5% |
| 11/6/2023 | $-1.10 | $-0.67 | +39.1% | $28.6M | $8.6M | -70.1% |
| 8/7/2023 | $-0.42 | $-1.25 | -197.6% | — | Pending | — |
| 5/8/2023 | $-1.41 | $-1.76 | -24.8% | $200,000 | Pending | — |
| 2/27/2023 | $-1.39 | $-1.25 | +10.1% | $200,000 | Pending | — |
| 11/7/2022 | $-1.23 | $-1.17 | +4.9% | — | Pending | — |
| 8/8/2022 | $-1.08 | $-1.10 | -1.9% | — | Pending | — |
| 5/9/2022 | $-1.05 | $-1.99 | -89.5% | — | Pending | — |
| 2/28/2022 | $-0.76 | $-0.94 | -23.7% | — | Pending | — |
| 11/8/2021 | $-0.75 | $-0.70 | +6.7% | — | Pending | — |
| 8/9/2021 | $-0.74 | $-0.74 | 0.0% | — | Pending | — |
| 5/10/2021 | $-0.55 | $-0.74 | -34.5% | — | Pending | — |
| 3/1/2021 | $-0.55 | $-0.53 | +3.6% | — | Pending | — |
| 11/9/2020 | $-0.44 | $-0.49 | -11.4% | — | Pending | — |
| 8/10/2020 | $-0.42 | $-0.37 | +11.9% | — | Pending | — |
| 5/4/2020 | $-0.42 | $-0.31 | +26.2% | — | Pending | — |
| 3/10/2020 | $-0.33 | $-0.31 | +6.1% | — | Pending | — |
| 11/4/2019 | $-0.39 | $-0.25 | +35.9% | — | Pending | — |
| 8/5/2019 | $-0.31 | $-0.37 | -19.4% | $469,621.62 | $542,000 | +15.4% |
| 5/7/2019 | $-0.35 | $-0.29 | +17.1% | $663,413.79 | $583,000 | -12.1% |
| 3/12/2019 | $-0.24 | $-0.28 | -16.7% | $435,296.3 | $1.0M | +135.9% |
| 11/5/2018 | $-0.25 | $-0.26 | -4.0% | $216,000 | $217,000 | +0.5% |
| 8/6/2018 | $-0.26 | $-0.22 | +15.4% | $267,363.64 | $173,000 | -35.3% |
| 5/7/2018 | $-0.48 | $-0.21 | +56.3% | $290,285.71 | $127,000 | -56.2% |
| 3/12/2018 | $-0.23 | $-0.26 | -13.0% | — | Pending | — |
| 11/13/2017 | $-0.74 | $-1.26 | -70.3% | — | Pending | — |
| 9/20/2017 | — | $-0.12 | — | — | Pending | — |
| 6/30/2017 | — | $-0.09 | — | — | Pending | — |
| 12/31/2016 | — | $-0.15 | — | — | Pending | — |
| 9/30/2016 | — | $-0.08 | — | — | Pending | — |